Skip to content
value.today

Cala Health, Inc.

Formerly Resido Medical, Inc.

Total raised
$166 M
5 rounds on record
Latest round
$48 M
Nov 2024
First round on record
Jan 2016
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Cala Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2024$48 MNo. 5$10 to $50 million

Cala Health, Inc.: Raise no. 5, Nov 2024

Investors in this round

41 investors had bought by the notice of Dec 9, 2024: 41 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$48 M of $51 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Deanna Harshbarger · Executive Officer, Director
  • Greg Enxing Schulte · Executive Officer
  • Kathryn Rosenbluth · Executive Officer, Director
  • Steve Enxing Higa · Executive Officer
  • James Lee · Director
  • John Kuelper · Director
  • Jordi Parramon · Director
  • Juan-Pablo Mas · Director
  • Michael Carusi · Director
  • Neil Enxing Tiwari · Director
  • Stacy Enxing Seng · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “"""Total Amount Sold"" includes conversion of outstanding indebtedness in the amount of $5,220,748.47."”

Signed by Deanna Harshbarger, Chief Executive Officer. Newest notice filed Dec 9, 2024. Read the notice at the SEC.

equitySEC
Nov 2021$38 MNo. 4$10 to $50 million

Cala Health, Inc.: Raise no. 4, Nov 2021

Investors in this round

25 investors had bought by the notice of Nov 16, 2021: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$38 M of $50 M offered; $12 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kate Rosenbluth · Executive Officer, Director
  • Renee Ryan · Executive Officer, Director
  • Amy Len Kobe · Director
  • Asha Nayak · Director
  • John Kuelper · Director
  • Michael Carusi · Director
  • Neil Tiwari · Director
  • Stacy Enxing Seng · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Renee Ryan, President and CEO. Newest notice filed Nov 16, 2021. Read the notice at the SEC.

equitySEC
May 2019$50 MNo. 3$50 to $250 million

Cala Health, Inc.: Raise no. 3, May 2019

Investors in this round

17 investors had bought by the notice of May 31, 2019: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$50 M of $51 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kate Rosenbluth · Executive Officer, Director
  • Michael A. Carusi · Director
  • Nicole Walker · Director
  • Renee Ryan · Director
  • Scott Delp · Director
  • Stacy Enxing A. Seng · Director
  • Ted A. Koutouzis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Amount Sold includes the conversion of $5,074,130 worth of convertible notes.”

Signed by Kathryn Rosenbluth, President and CEO. Newest notice filed May 31, 2019. Read the notice at the SEC.

equitySEC
May 2018$12 MNo. 2$10 to $50 million

Cala Health, Inc.: Raise no. 2, May 2018

Investors in this round

13 investors had bought by the notice of May 31, 2019: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $12 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kate Rosenbluth · Executive Officer, Director
  • Michael A. Carusi · Director
  • Nicole Walker · Director
  • Renee Ryan · Director
  • Scott Delp · Director
  • Stacy Enxing A. Seng · Director
  • Ted A. Koutouzis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kathryn Rosenbluth, President and CEO. Newest notice filed May 31, 2019. Read the notice at the SEC.

equitySEC
Jan 2016$18 MNo. 1$10 to $50 million

Cala Health, Inc.: Raise no. 1, Jan 2016

Investors in this round

15 investors had bought by the notice of Feb 16, 2016: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $18 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kate Rosenbluth · Executive Officer, Director
  • Serena Wong · Executive Officer
  • Terry Sanger · Executive Officer
  • Mark A. Deem · Director
  • Michael A. Carusi · Director
  • Renee Ryan · Director
  • Robert Paull · Director
  • Scott Delp · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David J. Saul, Secretary. Newest notice filed Feb 16, 2016. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Cala Health, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2024).

    SEC Form D · Dec 2024

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2024

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Cala Health, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Cala Health, Inc.
NameRoleNamed in
Deanna HarshbargerExecutive officerDec 2024
Greg Enxing SchulteExecutive officerDec 2024
Kathryn RosenbluthExecutive officerDec 2024
Steve Enxing HigaExecutive officerDec 2024
Kate RosenbluthExecutive officerNov 2021
Renee RyanExecutive officerNov 2021
Serena WongExecutive officerFeb 2016
Terry SangerExecutive officerFeb 2016
Deanna HarshbargerDirectorDec 2024
James LeeDirectorDec 2024
John KuelperDirectorDec 2024
Jordi ParramonDirectorDec 2024
Juan-Pablo MasDirectorDec 2024
Kathryn RosenbluthDirectorDec 2024
Michael CarusiDirectorDec 2024
Neil Enxing TiwariDirectorDec 2024
Stacy Enxing SengDirectorDec 2024
Amy Len KobeDirectorNov 2021
Asha NayakDirectorNov 2021
Kate RosenbluthDirectorNov 2021
Neil TiwariDirectorNov 2021
Renee RyanDirectorNov 2021
Michael A. CarusiDirectorMay 2019
Nicole WalkerDirectorMay 2019
Scott DelpDirectorMay 2019
Stacy Enxing A. SengDirectorMay 2019
Ted A. KoutouzisDirectorMay 2019
Mark A. DeemDirectorFeb 2016
Robert PaullDirectorFeb 2016